Clinical Management of Acute Portal/Mesenteric Vein Thrombosis

Overview

Journal Viszeralmedizin

Publisher Karger

Date 2015 Aug 20

PMID 26285602

Citations 12

Authors

Sven A Lang

Martin Loss

Walter A Wohlgemuth

Hans J Schlitt

Affiliations

Soon will be listed here.

Abstract

Background: Acute thrombosis of the portal vein (PV) and/or the mesenteric vein (MV) is a rare but potentially life-threatening disease. A multitude of risk factors for acute portal vein thrombosis (PVT)/mesenteric vein thrombosis (MVT) have been identified, including liver cirrhosis, malignancy, coagulation disorders, intra-abdominal infection/inflammation, and postoperative condition.

Methods: This article analyses the treatment options for acute PVT/MVT.

Results: Initially, the clinical management should identify patients with an intra-abdominal focus requiring immediate surgical intervention (e.g. bowel ischaemia). Subsequently, emphasis is placed on the recanalization of the PV/MV or at least the prevention of thrombus extension to avoid long-term complications of portal hypertension. Several therapeutic options are currently available, including anticoagulation therapy, local/systemic thrombolysis, interventional or surgical thrombectomy, and a combination of these procedures. Due to the lack of prospective randomized studies, a comparison between these therapeutic approaches regarding the efficacy of PV/MV recanalization is difficult, if not impossible.

Conclusion: In patients with acute PVT/MVT, an individualized treatment based on the clinical presentation, the underlying disease, the extent of the thrombosis, and the patients' comorbidities is mandatory. Therefore, these patients should be considered for an interdisciplinary therapy in specialized centres with the option to utilise all therapeutic approaches currently available.

Citing Articles

Association Between Venous Mesenteric Thrombosis and Plasminogen Activator Inhibitor-1 Mutation.

Pereira V, Castanheira D, Sanches M, Castro Silva B, Almeida R Cureus. 2025; 16(12):e75974.

PMID: 39840212 PMC: 11747969. DOI: 10.7759/cureus.75974.

A Rare Case of Portal Vein Thrombosis Following a Successful Laparoscopic Cholecystectomy.

Sood R, Seth M, Kundal S, Singh R, Kapoor B Cureus. 2022; 14(10):e30294.

PMID: 36407126 PMC: 9658484. DOI: 10.7759/cureus.30294.

Covid19 vaccination-associated portal vein thrombosis-An interdisciplinary clinical challenge.

Bogovic N, Doenecke A, Hart C, Lurken L, Heimerl S, Eissnert C Clin Res Hepatol Gastroenterol. 2022; 46(8):101932.

PMID: 35504460 PMC: 9055786. DOI: 10.1016/j.clinre.2022.101932.

Anticoagulation in patients with advanced liver disease: an open issue.

Violi F, Loffredo L, Pastori D Intern Emerg Med. 2020; 16(1):61-71.

PMID: 33073317 DOI: 10.1007/s11739-020-02526-6.

Role of imaging in visceral vascular emergencies.

Karaosmanoglu A, Uysal A, Akata D, Ozmen M, Karcaaltincaba M Insights Imaging. 2020; 11(1):112.

PMID: 33057847 PMC: 7561664. DOI: 10.1186/s13244-020-00913-3.

References

Jun K, Kim M, Park K, Chun H, Hong K, Jeon Y . Mechanical thrombectomy-assisted thrombolysis for acute symptomatic portal and superior mesenteric venous thrombosis. Ann Surg Treat Res. 2014; 86(6):334-41. PMC: 4062453. DOI: 10.4174/astr.2014.86.6.334. View

Ponziani F, Zocco M, Campanale C, Rinninella E, Tortora A, Di Maurizio L . Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment. World J Gastroenterol. 2010; 16(2):143-55. PMC: 2806552. DOI: 10.3748/wjg.v16.i2.143. View

Chawla Y, Duseja A, Dhiman R . Review article: the modern management of portal vein thrombosis. Aliment Pharmacol Ther. 2009; 30(9):881-94. DOI: 10.1111/j.1365-2036.2009.04116.x. View

Amitrano L, Guardascione M, Menchise A, Martino R, Scaglione M, Giovine S . Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis. J Clin Gastroenterol. 2009; 44(6):448-51. DOI: 10.1097/MCG.0b013e3181b3ab44. View

Hall T, Garcea G, Metcalfe M, Bilku D, Dennison A . Management of acute non-cirrhotic and non-malignant portal vein thrombosis: a systematic review. World J Surg. 2011; 35(11):2510-20. DOI: 10.1007/s00268-011-1198-0. View

Handa P, Crowther M, Douketis J . Portal vein thrombosis: a clinician-oriented and practical review. Clin Appl Thromb Hemost. 2013; 20(5):498-506. DOI: 10.1177/1076029612473515. View

Oguzkurt P, Tercan F, Ince E, Ezer S, Hicsonmez A . Percutaneous treatment of portal vein thrombosis in a child who has undergone splenectomy. J Pediatr Surg. 2008; 43(8):e29-32. DOI: 10.1016/j.jpedsurg.2008.04.005. View

Parikh S, Shah R, Kapoor P . Portal vein thrombosis. Am J Med. 2010; 123(2):111-9. DOI: 10.1016/j.amjmed.2009.05.023. View

Doenecke A, Tsui T, Zuelke C, Scherer M, Schnitzbauer A, Schlitt H . Pre-existent portal vein thrombosis in liver transplantation: influence of pre-operative disease severity. Clin Transplant. 2009; 24(1):48-55. DOI: 10.1111/j.1399-0012.2009.00977.x. View

10.

Kinjo N, Kawanaka H, Akahoshi T, Matsumoto Y, Kamori M, Nagao Y . Portal vein thrombosis in liver cirrhosis. World J Hepatol. 2014; 6(2):64-71. PMC: 3934638. DOI: 10.4254/wjh.v6.i2.64. View

11.

Uflacker R . Applications of percutaneous mechanical thrombectomy in transjugular intrahepatic portosystemic shunt and portal vein thrombosis. Tech Vasc Interv Radiol. 2003; 6(1):59-69. DOI: 10.1053/tvir.2003.36433. View

12.

Senzolo M, M Sartori T, Rossetto V, Burra P, Cillo U, Boccagni P . Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis. Liver Int. 2012; 32(6):919-27. DOI: 10.1111/j.1478-3231.2012.02785.x. View

13.

Tsochatzis E, Senzolo M, Germani G, Gatt A, Burroughs A . Systematic review: portal vein thrombosis in cirrhosis. Aliment Pharmacol Ther. 2009; 31(3):366-74. DOI: 10.1111/j.1365-2036.2009.04182.x. View

14.

Novellas S, Denys A, Bize P, Brunner P, Motamedi J, Gugenheim J . Palliative portal vein stent placement in malignant and symptomatic extrinsic portal vein stenosis or occlusion. Cardiovasc Intervent Radiol. 2008; 32(3):462-70. DOI: 10.1007/s00270-008-9455-9. View

15.

Dentali F, Squizzato A, Brivio L, Appio L, Campiotti L, Crowther M . JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis. Blood. 2009; 113(22):5617-23. DOI: 10.1182/blood-2008-12-196014. View

16.

Singal A, Kamath P, Tefferi A . Mesenteric venous thrombosis. Mayo Clin Proc. 2013; 88(3):285-94. DOI: 10.1016/j.mayocp.2013.01.012. View

17.

Rodriguez-Castro K, Porte R, Nadal E, Germani G, Burra P, Senzolo M . Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation: a systematic review. Transplantation. 2012; 94(11):1145-53. DOI: 10.1097/TP.0b013e31826e8e53. View

18.

Loss M, Lang S, Uller W, Wohlgemuth W, Schlitt H . Combined surgical and interventional therapy of acute portal vein thrombosis without cirrhosis: a new effective hybrid approach for recanalization of the portal venous system. J Am Coll Surg. 2014; 218(3):e79-86. DOI: 10.1016/j.jamcollsurg.2013.11.010. View

19.

Liu F, Wang M, Fan Q, Duan F, Wang Z, Song P . Interventional treatment for symptomatic acute-subacute portal and superior mesenteric vein thrombosis. World J Gastroenterol. 2009; 15(40):5028-34. PMC: 2768881. DOI: 10.3748/wjg.15.5028. View

20.

Chok K, Cheung T, Chan S, Poon R, Fan S, Lo C . Surgical outcomes in hepatocellular carcinoma patients with portal vein tumor thrombosis. World J Surg. 2013; 38(2):490-6. DOI: 10.1007/s00268-013-2290-4. View